Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

作者: Martin Widschwendter , Jennifer Berger , Hannes M. Müller , Alain G. Zeimet , Christian Marth

DOI: 10.1023/A:1011360724350

关键词:

摘要: A growing body of evidence supports the hypothesis that retinoic acid receptor beta2 (RAR-beta2) gene is a tumor suppressor which induces apoptosis and chemopreventive therapeutic effects retinoids are due to induction RAR-beta2. During breast cancer progression, RAR-beta2 reduced or even lost. It known from studies other tumor-suppressor genes methylation 5'-region cause loss expression. Several groups demonstrated this also true for in by treating cell lines with demethylating agent examining expression response challenge acid. Studies using sodium bisulfite genomic sequencing as well specific PCR showed number tissue signs methylation. The was unmethylated non-neoplastic normal tissues. combination agents histone deacetylase inhibitors acts synergistically inhibit growth. This review presents data suggest treatment patients followed may offer new modality. Both time commencement chemoprevention choice substances able either prevent de novo reverse methylation-caused silencing be important considerations.

参考文章(69)
D L Newton, M B Sporn, Chemoprevention of cancer with retinoids. Federation proceedings. ,vol. 38, pp. 2528- 2534 ,(1979)
Lawrence M. Mielnicki, Harold L. Asch, Bonnie B. Asch, Genes, chromatin, and breast cancer: an epigenetic tale. Journal of Mammary Gland Biology and Neoplasia. ,vol. 6, pp. 169- 182 ,(2001) , 10.1023/A:1011356623442
H. de The, A. Marchio, P. Tiollais, A. Dejean, Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. The EMBO Journal. ,vol. 8, pp. 429- 433 ,(1989) , 10.1002/J.1460-2075.1989.TB03394.X
Fyodor D. Urnov, Alan P. Wolffe, Above and within the genome: epigenetics past and present. Journal of Mammary Gland Biology and Neoplasia. ,vol. 6, pp. 153- 167 ,(2001) , 10.1023/A:1011304606604
Elizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen, James G. Herman, Stephen B. Baylin, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nature Genetics. ,vol. 21, pp. 103- 107 ,(1999) , 10.1038/5047
Reuben Lotan, Eiichi Tahara, Xiao Chun Xu, Scott M. Lippman, Xiaoming Liu, Expression and Up-Regulation of Retinoic Acid Receptor-β Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines Cancer Research. ,vol. 59, pp. 2477- 2483 ,(1999)
Gangning Liang, Peter A. Jones, Cathy Talmadge, Keith D. Robertson, Janos Sumegi, The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Research. ,vol. 60, pp. 4907- 4912 ,(2000)
Martin Widschwendter, Otto Dapunt, Günter Daxenbichler, Christian Marth, Effects of Retinoic Acid and γ-Interferon on Expression of Retinoic Acid Receptor and Cellular Retinoic Acid-binding Protein in Breast Cancer Cells Cancer Research. ,vol. 55, pp. 2135- 2139 ,(1995)
Andreas Widschwendter, Martin Widschwendter, Elisabeth Müller-Holzner, Alain G. Zeimet, Günter Daxenbichler, Jennifer Berger, Adelcy Mayr, Christian Marth, Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer Cancer Research. ,vol. 57, pp. 4158- 4161 ,(1997)
Gabriel Hortobagyi, Reuben Lotan, Raju Nandagiri, Nour Sneige, Xiao Chun Xu, Scott M. Lippman, J. Jack Lee, Farzana Lukmanji, Xiaoming Liu, Kapil Dhingra, Kapil Dhingra, Progressive Decrease in Nuclear Retinoic Acid Receptor β Messenger RNA Level during Breast Carcinogenesis Cancer Research. ,vol. 57, pp. 4992- 4996 ,(1997)